- Friday, March 31, 2023
6:00 AM – 7:00 AM
Yoga & Meditation
6:00 AM – 7:00 AM
Yoga & Meditation
Location: 150-151
7:00 AM – 8:00 AM
CE Symposia: Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy
7:00 AM – 8:00 AM
CE Symposia: Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy Location: 159*Speaker: – The James Cancer Hospital Columbus, Ohio
*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
*Speaker: – Memorial Sloan Kettering Cancer Center
Emily Dotson, PharmD, BCOP – The James Cancer Hospital Columbus, Ohio ### 957908###*Speaker######The James Cancer Hospital Columbus, Ohio###*Speaker: – The James Cancer Hospital Columbus, Ohio
### @@@ Peter Campbell, PharmD, MBA, BCOP – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center ### 1589099###*Speaker######NewYork-Presbyterian Hospital, Columbia University Irving Medical Center###*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
### @@@ Sarah E. Stump, PharmD, BCPS, BCOP – Memorial Sloan Kettering Cancer Center ### 1195640###*Speaker###Clinical Pharmacy Specialist - Leukemia###Memorial Sloan Kettering Cancer Center###*Speaker: – Memorial Sloan Kettering Cancer Center
### 7:00 AM – 8:00 AM
CE Symposia: The Pharmacist View: Key Considerations for Optimal Myelofibrosis
7:00 AM – 8:00 AM
CE Symposia: The Pharmacist View: Key Considerations for Optimal Myelofibrosis Management Location: 157*Speaker: – University of Colorado School of Medicine Anschutz Medical Campus
*Speaker: – University of Michigan Rogel Cancer Center
*Speaker: – The University of Texas MD Anderson Cancer Center
Brandon McMahon, MD – University of Colorado School of Medicine Anschutz Medical Campus ### 1917223###*Speaker###Professor of Medicine###University of Colorado School of Medicine Anschutz Medical Campus###*Speaker: – University of Colorado School of Medicine Anschutz Medical Campus
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###*Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###*Speaker: – University of Michigan Rogel Cancer Center
### @@@ Shilpa Paul, PharmD, BCOP – The University of Texas MD Anderson Cancer Center ### 894800###*Speaker###Clinical Pharmacy Specialist- Leukemia###The University of Texas MD Anderson Cancer Center###*Speaker: – The University of Texas MD Anderson Cancer Center
### 7:00 AM – 8:00 AM
CE Symposia: Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care
7:00 AM – 8:00 AM
CE Symposia: Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient CareLocation: 158*Speaker: – Emory Healthcare
*Speaker: – University of Kansas Cancer Center
*Speaker:
Kathryn Maples, PharmD, BCOP – Emory Healthcare ### 1459174###*Speaker###Clinical Pharmacy Specialist, Multiple Myeloma###Emory Healthcare###*Speaker: – Emory Healthcare
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP (she/her/hers) – University of Kansas Cancer Center ### 958456###*Speaker###Clinical Pharmacy Manager-Hem/BMT/CAR-T###University of Kansas Cancer Center###*Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ Tyler Sandahl, PharmD, BCOP, RPh ### 1896149###*Speaker#########*Speaker:
### 7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
Location: Exhibit Hall
8:00 AM – 9:00 AM
Significant Updates in Hematology
8:00 AM – 9:00 AM
301 - Significant Updates in HematologyLocation: 160-163Speaker: – Norton Cancer Institute
Rebecca Champion, PharmD, BCOP (she/her/hers) – Norton Cancer Institute ### 1792809###Speaker###Clinical Pharmacy Manager###Norton Cancer Institute###Speaker: – Norton Cancer Institute
### she/her/hers
8:00 AM – 9:00 AM
Turning Up the Heat on Melanoma: Exploring Novel Immunotherapies in the Classic “Hot” Tumor
8:00 AM – 9:00 AM
BC5 - Turning Up the Heat on Melanoma: Exploring Novel Immunotherapies in the Classic “Hot” TumorLocation: BallroomSpeaker: – Beth Israel Deaconess Medical Center
BCOP
Julia Stevens, PharmD, BCOP – Beth Israel Deaconess Medical Center ### 947694###Speaker###Clinical Pharmacy Specialist - Ambulatory Oncology###Beth Israel Deaconess Medical Center###Speaker: – Beth Israel Deaconess Medical Center
###
9:15 AM – 10:15 AM
Clinical Utility of Germline Pharmacogenetic Testing in Patients with Cancer
9:15 AM – 10:15 AM
303 - Clinical Utility of Germline Pharmacogenetic Testing in Patients with CancerLocation: BallroomSpeaker: – Levine Cancer Institute, Atrium Health
Jai N. Patel, PharmD, BCOP, CPP (he/him/his) – Levine Cancer Institute, Atrium Health ### 1171470###Speaker###Chair, Department of Cancer Pharmacology & Pharmacogenomics###Levine Cancer Institute, Atrium Health###Speaker: – Levine Cancer Institute, Atrium Health
### he/him/his
9:15 AM – 10:15 AM
Gaining Traction: Novel Targets and Treatment Strategies in Biliary Tract Cancer
9:15 AM – 10:15 AM
302 - Gaining Traction: Novel Targets and Treatment Strategies in Biliary Tract CancerLocation: 160-163
Mark L. Zangardi, PharmD, MS, BCOP (he/him/his) – OhioHealth ### 1774207###Speaker###Pharmacy Coordinator, Oncology Precision Medicine###OhioHealth###Speaker: – OhioHealth
### he/him/his
9:15 AM – 10:15 AM
Grab that Iron! Practical Considerations of Iron Chelation
9:15 AM – 10:15 AM
304 - Grab that Iron! Practical Considerations of Iron ChelationLocation: 164-167
Catherine Martin, PharmD, BCOP (she/her/hers) – Mayo Clinic ### 1808423###Speaker###Clinical Pharmacist###Mayo Clinic###Speaker: – Mayo Clinic
### she/her/hers
9:15 AM – 10:15 AM
Microsatellite Instability in Early-Stage Colorectal Cancer: Are the Data Strong or Still Shaky?
9:15 AM – 10:15 AM
302 - Microsatellite Instability in Early-Stage Colorectal Cancer: Are the Data Strong or Still Shaky?Location: 160-163Speaker: – The Ohio State University James Comprehensive Cancer Center
Matthew Arango, PharmD, BCOP – The Ohio State University James Comprehensive Cancer Center ### 1177730###Speaker###Specialty Practice Pharmacist###The Ohio State University James Comprehensive Cancer Center###Speaker: – The Ohio State University James Comprehensive Cancer Center
###
9:15 AM – 10:15 AM
The Chicken or the Egg? Adverse Effect Management for Novel Drug Combinations in the Era of Oncology Precision Medicine
9:15 AM – 10:15 AM
303 - The Chicken or the Egg? Adverse Effect Management for Novel Drug Combinations in the Era of Oncology Precision MedicineLocation: BallroomSpeaker: – Froedtert & the Medical College of Wisconsin
Carolyn Oxencis, PharmD, BCOP (she/her/hers) – Froedtert & the Medical College of Wisconsin ### 1774211###Speaker###Pharmacogenomics and Oncology Precision Medicine Pharmacist###Froedtert & the Medical College of Wisconsin###Speaker: – Froedtert & the Medical College of Wisconsin
### she/her/hers
9:15 AM – 10:15 AM
What’s Cooler Than Being Cool: Updates in Cold Agglutinin Disease
9:15 AM – 10:15 AM
304 - What’s Cooler Than Being Cool: Updates in Cold Agglutinin Disease Location: 164-167Speaker: – Michigan Medicine
Madeleine A. Ochs, PharmD, BCOP – Michigan Medicine ### 1252118###Speaker###Clinical Pharmacist Specialist, Inpatient Hematology###Michigan Medicine###Speaker: – Michigan Medicine
###
10:15 AM – 10:45 AM
Member Awards + Business Meeting
10:15 AM – 10:45 AM
Member Awards + Business Meeting
Location: Ballroom
11:00 AM – 12:00 PM
Research Grant Award: Remote patient-reported quality of life outcomes in patients on oral anti-cancer therapy
11:00 AM – 12:00 PM
305 - Research Grant Award: Remote patient-reported quality of life outcomes in patients on oral anti-cancer therapyLocation: BallroomSpeaker: – Oregon Health and Science University
Research
Alison M. Palumbo, PharmD, MPH, BCOP (she/her/hers) – Oregon Health and Science University ### 1810471###Speaker###Clinical Oncology Pharmacist###Oregon Health and Science University###Speaker: – Oregon Health and Science University
### she/her/hers
12:00 PM – 1:00 PM
Non-CE Symposia: Discussing Anticancer Therapy Along With Patient Monitoring and Management of Adverse Events
12:00 PM – 1:00 PM
Non-CE Symposia: Discussing Anticancer Therapy Along With Patient Monitoring and Management of Adverse EventsLocation: 158
Mark Wagner, PharmD ### 1917234###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings.
PP-AL-US-2989 © Lilly USA, LLC 2021. All rights reserved.
12:00 PM – 1:00 PM
Non-CE Symposia: Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings.PP-AL-US-2989 © Lilly USA, LLC 2021. All rights reserved.Location: 157
Katheryn Moreira, MD, MBA ### 1939658###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: In Practice: Combination Treatment Options with IO in mNSCLC and uHCC
12:00 PM – 1:00 PM
Non-CE Symposia: In Practice: Combination Treatment Options with IO in mNSCLC and uHCC
Christopher Walczak, PharmD ### 1589100###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
Location: Ballroom Lobby
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Even #)
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Even #)Location: Exhibit HallResearch
1:00 PM – 2:00 PM
2023 Patient Advocacy Session
1:00 PM – 2:00 PM
Patient Advocacy: Empowering Our Patients to Become Self-Advocates: Improving Patient Care Together (Non-CE)Location: 160-163*Speaker: – West Virginia University Medicine
Advocacy
Jordan Hill, PharmD, BCOP – West Virginia University Medicine ### 1772979###*Speaker###Clinical Pharmacy Specialist - Oncology###West Virginia University Medicine###*Speaker: – West Virginia University Medicine
###
2:30 PM – 3:00 PM
Incoming President's Remarks + Board Awards
2:30 PM – 3:00 PM
Incoming President's Remarks + Board Awards Location: BallroomPresenter: – Atrium Health Wake Forest Baptist (WFB)
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###Presenter###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###Presenter: – Atrium Health Wake Forest Baptist (WFB)
### 3:15 PM – 4:30 PM
Giving orphan drugs a home: A case-based approach to the management of rare leukemic entities
3:15 PM – 4:30 PM
BC6 - Giving orphan drugs a home: A case-based approach to the management of rare leukemic entitiesLocation: BallroomCo-Speaker: – Michigan Medicine, University of Michigan
Co-Speaker: – University of Michigan
BCOP
Lydia Benitez, PharmD, BCOP – Michigan Medicine, University of Michigan ### 1540118###Co-Speaker###Clinical Assistant Professor of Pharmacy###Michigan Medicine, University of Michigan###Co-Speaker: – Michigan Medicine, University of Michigan
### @@@ Bernard L. Marini, PharmD, BCOP (he/him/his) – University of Michigan ### 1254284###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan###Co-Speaker: – University of Michigan
### he/him/his
3:15 PM – 4:30 PM
Incorporating Social Determinants of Health and Sexual Orientation and Gender Identity Data Collection into Clinical Workflows
3:15 PM – 4:30 PM
306 - Incorporating Sexual Orientation and Gender Identity Data into Oncology Patient CareLocation: 160-163Co-Speaker: – Sutter Sacramento Medical Center
Co-Speaker: – Massachusetts College of Pharmacy & Health Sciences
Co-Speaker: – Eastern Idaho Regional Medical Center
Maya Leiva, PharmD, BCOP (she/her/hers) – Sutter Sacramento Medical Center ### 1774216###Co-Speaker###Senior Clinical Oncology Pharmacist###Sutter Sacramento Medical Center###Co-Speaker: – Sutter Sacramento Medical Center
### she/her/hers @@@ Christy S. Harris, PharmD, BCOP, FHOPA (she/her/hers) – Massachusetts College of Pharmacy & Health Sciences ### 1410926###Co-Speaker###Associate Professor of Pharmacy Practice###Massachusetts College of Pharmacy & Health Sciences###Co-Speaker: – Massachusetts College of Pharmacy & Health Sciences
### she/her/hers @@@ Leslie Harris, PharmD, BCOP (she/her/hers) – Eastern Idaho Regional Medical Center ### 1805701###Co-Speaker###Advanced Clinical Pharmacist Oncology ###Eastern Idaho Regional Medical Center ###Co-Speaker: – Eastern Idaho Regional Medical Center
### she/her/hers
4:45 PM – 5:45 PM
Beyond the Title: The Accidental or New Leader
4:45 PM – 5:45 PM
308 - Beyond the Title: The Accidental or New Leader Location: 160-163Speaker: – The Ohio State University Comprehensive Cancer Center
Practice Management
Julie Kennerly-Shah, PharmD, MS, MHA, BCPS – The Ohio State University Comprehensive Cancer Center ### 1774215###Speaker###Associate Director, Pharmacy###The Ohio State University Comprehensive Cancer Center###Speaker: – The Ohio State University Comprehensive Cancer Center
###
4:45 PM – 5:45 PM
Triplet Therapy for Metastatic Prostate Cancer
4:45 PM – 5:45 PM
307 - Three's a Crowd: Triplet Therapy for Metastatic Prostate CancerLocation: BallroomSpeaker: – University of Rochester Medical Center
Bryan Fitzgerald, PharmD, BCOP (he/him/his) – University of Rochester Medical Center ### 1774218###Speaker###Clinical Pharmacy Specialist###University of Rochester Medical Center###Speaker: – University of Rochester Medical Center
### he/him/his
6:00 PM – 7:00 PM
CE Symposia: Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions
6:00 PM – 7:00 PM
CE Symposia: Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions Location: 159*Speaker:
*Speaker: – University of Michigan Medicine
*Speaker: – University of Virginia Health System
Laura Bobolts, PharmD, BCOP ### 1896150###*Speaker#########*Speaker:
### @@@ Allison Schepers, PharmD, BCOP – University of Michigan Medicine ### 1094222###*Speaker###Clinical Pharmacist Specialist, Inpatient Medical Oncology###University of Michigan Medicine###*Speaker: – University of Michigan Medicine
### @@@ Andrew Whitman, PharmD – University of Virginia Health System ### 894808###*Speaker###Lead Clinical Pharmacist - Oncology/Hematology###University of Virginia Health System###*Speaker: – University of Virginia Health System
### 6:00 PM – 7:00 PM
CE Symposia: Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens
6:00 PM – 7:00 PM
CE Symposia: Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based RegimensLocation: 158*Speaker: – Duquesne University School of Pharmacy
*Speaker: – Emory Healthcare - Winship Cancer Institute
*Speaker: – University of Michigan Rogel Cancer Center
Karen Fancher, PharmD, BCOP – Duquesne University School of Pharmacy ### 894757###*Speaker###Assistant Professor of Pharmacy Practice###Duquesne University School of Pharmacy###*Speaker: – Duquesne University School of Pharmacy
### @@@ Arpita Gandhi, PharmD, BCOP – Emory Healthcare - Winship Cancer Institute ### 1774202###*Speaker###Hematology/Oncology Clinical Pharmacy Specialist###Emory Healthcare - Winship Cancer Institute###*Speaker: – Emory Healthcare - Winship Cancer Institute
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###*Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###*Speaker: – University of Michigan Rogel Cancer Center
### 7:00 PM – 9:00 PM
Closing Reception
7:00 PM – 9:00 PM
Closing Reception
Location: Ballroom Terrace
